series-a
Stage
2023
Founded
1
Investors
About
Expedition Therapeutics is a biotech company developing novel therapies for serious inflammatory and respiratory diseases, with a focus on targeting neutrophilic inflammation in chronic obstructive pulmonary disease (COPD) through its lead candidate, EXPD-101, a DPP1 inhibitor.
Explore Expedition Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.